Marshall Wace’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
+543,028
New +$1.38M ﹤0.01% 1985
2025
Q1
Sell
-42,010
Closed -$195K 2786
2024
Q4
$195K Hold
42,010
﹤0.01% 2360
2024
Q3
$292K Sell
42,010
-66,090
-61% -$519K ﹤0.01% 2158
2024
Q2
$843K Buy
+108,100
New +$801K ﹤0.01% 1765
2023
Q4
Sell
-342,496
Closed -$1.93M 2320
2023
Q3
$1.93M Buy
+342,496
New +$2.28M ﹤0.01% 1237
2023
Q2
Sell
-1,492,983
Closed -$9.33M 2637
2023
Q1
$9.33M Sell
1,492,983
-1,779,425
-54% -$9.92M 0.02% 738
2022
Q4
$15.2M Sell
3,272,408
-350,301
-10% -$1.73M 0.03% 584
2022
Q3
$16.9M Buy
3,622,709
+55,218
+2% +$348K 0.04% 535
2022
Q2
$21.1M Sell
3,567,491
-1,563
-0% -$17.4K 0.04% 443
2022
Q1
$69M Buy
3,569,054
+2,480,556
+228% +$56.9M 0.13% 160
2021
Q4
$35.6M Buy
1,088,498
+102,426
+10% +$4.12M 0.07% 297
2021
Q3
$40.4M Buy
986,072
+911,446
+1,221% +$33.1M 0.17% 115
2021
Q2
$2.69M Buy
74,626
+48,469
+185% +$1.79M 0.01% 1229
2021
Q1
$1.02M Buy
+26,157
New +$1.18M ﹤0.01% 1643
2020
Q4
Sell
-20,699
Closed -$1.15M 1980
2020
Q3
$1.15M Buy
+20,699
New +$1.1M 0.01% 977

Other funds holding GDRX

Marshall Wace's GDRX Position: Q2 2026 in Review

Marshall Wace opened a new position in GoodRx Holdings (GDRX) in Q2 2026: 543,028 shares worth $1.56M. The stake represents ﹤0.01% of the portfolio and ranks #1985 among its holdings. This is a return to the name: Marshall Wace previously reported a position in GDRX as recently as Q4 2024.

Marshall Wace first reported a position in GDRX in Q3 2020 and has held it in 15 quarters since. The position peaked at $69M in Q1 2022. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Marshall Wace held 543,028 shares of GoodRx Holdings worth $1.56M as of Q2 2026.
  • GoodRx Holdings was a new Marshall Wace position in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1985 holding.
  • Marshall Wace first reported a position in GoodRx Holdings in Q3 2020 and has held it in 15 quarters since.
  • Marshall Wace's GoodRx Holdings position peaked at $69M in Q1 2022.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.